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 While Interpersonal Psychotherapy (IPT) has proven to be an effective treatment 
for acute depression, the effectiveness of treatment in each of the four problem areas 
(grief, role transitions, role disputes, interpersonal deficits) has received little attention. 
The goal of this project was to provide some evidence for the specificity of IPT by 
comparing the success of treatment among patients whose treatment focused on each of 
the four problem areas. We hoped to understand how the patient characteristics and 
interpersonal problems most closely linked to the onset of an individual’s current 
depression contributed to the success of IPT, with a particular emphasis on the role of 
personality pathology. In this sample of 181 individuals suffering from acute unipolar 
depression, chi-square analyses and the Wilcoxon Rank Sum Test indicated that the level 
of personality pathology reported by study participants was quite similar across all 
problem area groups. This was true when personality pathology was measured both 
continuously and categorically. Contrary to prediction, survival analyses indicated that 
patients in each of the four problem area groups demonstrated similar time to remission 
from their depression. The meaning and significance of these findings is described below. 
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1.0 INTRODUCTION 
 
 
 
1.1 SIGNIFICANCE 
 
Depression is a pervasive, debilitating disorder that affects millions of individuals. The 
National Institute of Mental Health reported that about 9.5% of the population of the 
United States suffers from a depressive illness during any given year (2000). The World 
Health Organization (2007) reported that depression is one of the leading causes of 
disability worldwide, affecting nearly 121 million individuals. Despite the fact that 
depression can be reliably diagnosed and effectively treated, less than 25% of depression 
sufferers receive effective treatment (2007). 
 In an effort to provide relief for individuals who are afflicted with the disorder, 
several useful psychotherapies and pharmacotherapies have emerged in recent years. In 
addition to the more well known and widely disseminated cognitive and behavioral 
therapies (CBT; Beck, 1995; Beck, Rush, Shaw, & Emery, 1979; Leahy, 1996; Persons, 
Davidson, & Tompkins, 2000), interpersonal psychotherapy (IPT) has emerged as a 
 1
short-term, focused treatment whose effectiveness has been well supported by empirical 
research (Elkin et al., 1989; Frank et al., 1990; Frank, Kupfer, Wagner, McEachran, & 
Cornes, 1991; Klerman & Weissman, 1987; Reynolds et al., 1999). 
 However, there has also been an appeal to take a more critical look at the 
evidence for the specific efficacy of these therapies in recent years (e.g. Parker, Parker, 
Brotchie, & Stuart, 2006). In his review of psychotherapies, Wampold (2005) identified 
four phenomena that challenge the evidence of their utility: different psychotherapies 
actually produce similar results; there is a lack of evidence that supports specific effects 
of these psychotherapies; patients’ improvement in these psychotherapies may be a result 
of common factors, not specific effects; and treatment outcome may be related to the 
level of the therapist’s adherence to the psychotherapy. Thus, Parker and Fletcher (2007) 
argue that outcome research should move toward an understanding of the efficacy of 
psychotherapy treatment in specific contexts, not simply as a treatment of depression in 
general. This is the area of Wampold’s findings on which we choose to focus.  
 Parker and Fletcher (2007) explain, “we acknowledge that […] IPT may 
nevertheless be specifically effective in some circumstances, but that evidence of such 
specificity still needs to be demonstrated – presumably in more context-specific clinical 
syndromes that respect the intrinsic logic of the specific therapy” (p. 357). They charge 
us to “identify those candidate disorders and aetiological circumstances that might best 
reflect the theoretical rationale for each therapy” (p. 357). Parker and colleagues (2006) 
also note that “the four interpersonal problem areas addressed in IPT […] have not been 
studied with respect to their outcome” (p. 7). They identify the need for such an 
investigation, given that the problem areas are a defining feature of IPT.  
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1.2 HISTORY 
 
Interpersonal Psychotherapy (IPT) was developed by Gerald L. Klerman and 
collaborators in the late 1960’s and was subsequently published as a manual-based 
treatment for depression (Klerman, Weissman, Rounsaville, & Chevron, 1984). IPT is a 
short-term, focused treatment for which strong empirical support has been developed 
since its inception (Elkin et al., 1989; Frank et al., 1990; Frank et al., 1991; Klerman & 
Weissman, 1987; Markowitz & Weissman, 2004; Reynolds et al., 1999; Weissman & 
Markowitz, 1994). Despite its logical outgrowth from the earlier work of the 
interpersonal school of psychotherapy, IPT in fact developed from a clinical trial rather 
than psychological theory. Within the research setting of the New Haven-Boston 
Collaborative Research Project, Klerman and colleagues completed a study using 
masters’ level clinicians who conducted what the investigators thought would be a  
“placebo” contrast condition for pharmacotherapy. What they found was that the 
treatment was actually quite effective, thus leading to further investigation of this 
treatment and its elaboration and further specification as Interpersonal Psychotherapy 
(Weissman, 1994). 
 The theoretical basis for IPT follows from the work of Meyer and Sullivan, in 
which the social workers participating in the Boston-New Haven study were well 
schooled. Meyer emphasized the psychosocial features of an individual’s environment 
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and the current experiences and social relations of the individual (Klerman et al., 1984). 
Harry Stack Sullivan, in his contribution to the interpersonal school of psychiatry, was 
influenced by Adolf Meyer’s attention to the individual as the central unit of study 
(Sullivan, 1953). Sullivan defined psychiatry as the field of interpersonal relations, and 
noted that “there was an acute need for a discipline which was determined to study […] 
the interpersonal situations through which persons manifest mental health or mental 
disorder” (1953, p.18). Thus, we see the rationale behind Klerman and colleagues’ (1984) 
conception of IPT as strongly rooted in the interpersonal school of psychiatry.  
 4
  
 
 
 
2.0 INTERPERSONAL APPROACH TO DEPRESSION 
 
 
 
Even with Meyer and Sullivan’s placement of psychiatric disorders in an interpersonal 
context, we still might ask, how are interpersonal problems related to depression? One 
viewpoint, and the viewpoint of IPT, holds that disturbances in social relationships can 
lead to clinical psychopathology. Klerman and colleagues (1984) focus on attachment, 
explaining that humans are at risk for developing impaired social relationships if 
attachment is not properly formed, while Bowlby (1982) states that we are also 
vulnerable to depression if existing attachments are damaged. He makes the point that 
disturbances in interpersonal relationships are capable of generating future mental health 
difficulties, thus linking interpersonal problems and psychopathology. 
 Life events and social support can also play a role in the development of 
depression. Life events that occur both in childhood and in adulthood are associated with 
the development of depression (Brown & Harris, 1978; Bifulco, Brown, & Harris, 1987; 
Harris, Brown, & Bifulco, 1986). Similarly, Leucken (2000) found that those who lost a 
parent during childhood have a greater likelihood of depressive symptoms as an adult; 
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however, these recent findings also suggest that the quality of social interaction and 
support that the individual experiences after the loss can impact the development of 
psychopathology in that individual later in life. As early as 1975, Weiss noted that 
deficient social bonds are associated with depression and neurosis in adults. Henderson 
and colleagues (1978) took this one step further, finding that not only is a lack of social 
bonds associated with the development of neurosis, but that this association was strongest 
with regard to one’s most significant relationships.  
 Interpersonal disturbances are not the only factors related to depression; other 
factors such as genes, neurotransmitter levels, and other environmental stressors may also 
lead to the disease (National Institute of Mental Health, 2000). Nonetheless, the findings 
regarding social support, as well as the development of attachment and the disruption of 
existing attachments help to place depression in an interpersonal context. Parker’s group 
summarizes this cogently: “underpinned by attachment, interpersonal and social theories, 
IPT assumes that an acute psychosocial stressor, in conjunction with insufficient social 
support, can lead to depressive symptoms” (Parker et al., 2006, p.2). 
 6
  
 
3.0 FORMAT OF INTERPERSONAL PSYCHOTHERAPY 
 
 
 
Interpersonal psychotherapy aims to focus on the patient’s1 current depressive symptoms 
and interpersonal relationships, not those of the past (Klerman et al., 1984). At the outset 
of treatment a substantial amount of time is spent identifying the most significant people 
in the patient’s life and describing the relationships among them, termed the interpersonal 
inventory (Klerman et al., 1984; Weissman, Markowitz, & Klerman, 2000). The 
underlying premise in IPT is that “disturbances in social roles can serve as antecedents 
for clinical psychopathology” (1984, p. 47); if the therapist and patient can remedy the 
interpersonal problem they may be able to reduce the resulting psychopathology 
(Markowitz, Bleiberg, Christos, & Levitan, 2006). 
 Treatment begins by reviewing the patient’s symptoms, explaining how 
depression is treated using IPT, and assigning the “sick role” to the patient (Klerman et 
al., 1984). The therapist and patient then complete the interpersonal inventory. The initial 
sessions conclude with an assessment of the need for medication, an explanation of 
depression in a social context, and the therapist linking the patient’s depression to his or 
her interpersonal situation (Klerman et al., 1984; Weissman et al., 2000).  
                                                 
1 We will use the term ‘patient’ as opposed to ‘client’ here as this is consistent with the majority of the IPT 
literature, as well as the original IPT manual (Klerman, Weissman, Rounsaville & Chevron, 1984). See 
Stuart and Robertson (2003, p. x) for further explanation. 
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 One of the ways the therapist explains the patient’s depression in an interpersonal 
context is by assigning the patient’s problems to one of four problem areas: grief, role 
transitions, role disputes, or interpersonal deficits. A patient’s problems may fit into one 
or two problem areas, and the problem area focus may also change throughout the course 
of treatment (Weissman et al., 2000). The initial phase of treatment typically lasts 1-3 
sessions, and concludes with the agreement of the patient and therapist as to which of the 
problem areas best addresses the patient’s current distress. This process is a collaborative 
one, in which the therapist and patient temporally link the patient’s current depressive 
episode to recent life events or other factors that may have contributed to the depression 
(Stuart & Robertson, 2003; Weissman et al., 2000).  
 At times, the patient and therapist may disagree about the most appropriate 
problem area; when this occurs, Weissman and colleagues (2000) suggest it may be 
necessary to accept the patient’s goals temporarily. However, it is possible that the focus 
of treatment may later shift to the problem area that the therapist had originally felt was 
the best fit for the patient (2000); thus, therapy may continue despite initial disagreement.  
 The grief problem area focuses on “abnormal grief reactions that result from 
failure to progress through the various phases of the normal mourning process” (Klerman 
et al., 1984, pp.96-98). Work in this area aims to “facilitate the delayed mourning 
process” and “help the patient reestablish interests and relationships that can substitute 
for what has been lost” (Weissman et al., 2000, p. 64).  
 The role disputes problem area focuses on nonreciprocal role expectations that 
exist between the patient and one or more significant others in the patient’s life (Klerman 
et al., 1984). For example, a patient who has chronic problems within her marriage may 
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conceptualize her distress as role disputes if this is the conflict that most closely led to her 
depression. The dispute might entail a disagreement over marital roles in the household. 
Klerman and colleagues note that role disputes can lead to depression because the feeling 
of losing control in the dispute can lead to a loss of self-esteem, in turn leading to 
depression. Thus, the therapist aims to help the patient “modify maladaptive 
communication patterns or reassess expectations” for the relevant relationship(s) 
(Klerman et al., 1984, p.105).  
 The role transitions problem area focuses on situations in which the patient has 
difficulty adapting to changes in key social roles, especially ones experienced as a loss; 
this difficulty can lead to feelings of helplessness and depressive symptoms in the patient 
(Klerman et al., 1984). Here, the therapist aims to help the patient experience the 
emotions associated with giving up the old role, attain new social skills and social 
supports (1984), and identify positive features of the new role (Weissman et al., 2000).  
 The interpersonal deficits problem area is assigned to those individuals who lack 
sufficient interpersonal relationships or who have difficulty maintaining the relationships 
that might exist (Klerman et al., 1984). This problem area is also assigned to patients who 
may have symptoms that were not adequately resolved in the past, and that interfere with 
current relationships (Weissman et al., 2000). The therapist reviews the patient’s previous 
social relationships in order to identify common problems that arise in each; he or she 
then looks for similarities in the patient’s relationship with the therapist, with the hope of 
modeling how to develop new rewarding relationships (1984). This problem area, more 
than the others, tends to explore some of the patient’s past relationships, in addition to 
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existing ones (1984). In general, the problem area upon which the patient and therapist 
focus is typically the one that contributes most to the patient’s depression (2000). 
 Once one of the problem areas is identified, the patient and therapist work 
collaboratively to resolve the pressing interpersonal problem, utilizing the appropriate 
strategies that correspond to each problem area (Klerman et al., 1984). The final phase 
focuses on preparing for termination, developing post-treatment coping strategies, and 
assessing the need for continuation treatment (1984). Typically, treatment for acute 
depression using IPT lasts 12 to 16 sessions in total (Markowitz & Weissman, 2004).  
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4.0 EFFICACY OF INTERPERSONAL PSYCHOTHERAPY 
 
 
 
In general, IPT has proven to be equally effective, if not more effective, in treating acute 
depression as other treatment options (c.f.., Hollon et al., 2005). One of the earliest 
studies of acute depression examined IPT and amitriptyline, alone and in combination, as 
compared to a nonscheduled treatment control condition (Klerman & Weissman, 1987). 
This study found that each of the active treatments was more effective than the control 
treatment, while their combination was more effective than either treatment alone. 
However, at a one year follow-up, patients who had received IPT, alone or in 
combination, were functioning better than those who had received amitriptyline alone or 
nonscheduled psychotherapy (1987). This study essentially replicated results from an 
earlier study of amitriptyline and psychotherapy, described as weekly 50-minute sessions 
that were “short-term, interpersonal, and focused on the social context of the depression” 
(Weissman et al., 1979, p. 556). While the main findings of both studies were consistent, 
the earlier study also found that at a one-year follow-up, those patients who had received 
IPT during the acute phase, with or without pharmacotherapy, displayed significantly 
better social functioning than those who did not receive IPT (Weissman, Klerman, 
Prusoff, Sholomskas, & Padian, 1981).  
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 Elkin and colleagues (1989) conducted a multi-site study of the effectiveness of 
four different treatments for depression in an outpatient setting: imipramine plus clinical 
management, IPT, cognitive-behavioral therapy (CBT), and placebo plus clinical 
management. In the overall sample, IPT fared as well as the other three treatments at 
reducing depressive symptoms. When analyzing patients with more severe levels of 
depression, both active medication and IPT were significantly more effective in reducing 
depressive symptomatology than placebo plus clinical management. The authors 
specifically note the clinical significance of how well IPT performed on the recovery 
criteria with the more functionally impaired patients (1989).  
 In addition to effectively treating acute depression, the interpersonal approach to 
treatment has made a valuable contribution as a maintenance treatment (IPT-M; e.g., 
Frank et al., 1991). While IPT’s prophylactic effect as a maintenance treatment was not 
as strong as active imipramine, Frank and colleagues (1990) found that monthly sessions 
of IPT-M alone significantly lengthened the time between depressive episodes. Reynolds, 
Frank, and colleagues (1999) also showed that IPT-M and nortiptyline individually were 
superior to placebo in lengthening the time to recurrence, while the combination of IPT 
and the drug was superior to either treatment alone in older adults with depression. In a 
recent study (Frank et al., 2007), IPT-M was found to be an equally effective 
prophylactic treatment for depression in women, regardless of whether IPT was provided 
weekly, bi-weekly or monthly. However, maintenance IPT was less effective among 
women who had previously required the addition of pharmacotherapy to achieve initial 
remission (2007). 
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 However, not all studies support the effectiveness of IPT above and beyond other 
treatments. For example, in a study of nortriptyline and IPT as treatments of 
bereavement-related depression in older adults, the authors found that there was no 
significant difference between IPT and placebo in effectiveness (Reynolds, Miller, et al., 
1999) and Shear, Frank, Houck, & Reynolds (2005) found that classic IPT was less 
effective than a version specifically enhanced to address the needs of those with 
complicated grief. Nonetheless, there appears to be substantial evidence supporting the 
effectiveness of IPT in treating acute depression, as well as other psychological disorders.                         
 Interestingly, thus far there appears to be only one study that examined the 
relationship between IPT problem area, probability of recovery, and patient 
characteristics (Wolfson et al., 1997). This study examined maintenance IPT in a 
population of elderly patients in which all patients received both IPT and nortriptyline as 
treatments. The authors found no significant differences in time to response among the 
problem areas; however, the interpersonal deficits group was excluded from analyses 
because of the small sample size (1997). Also, since all patients in this study received the 
drug we cannot attribute the changes in depressive symptoms to the IPT treatment alone. 
 Several studies involving IPT have shown that demographic and clinical variables 
are not related to long-term outcome of depression (Weissman, Prusoff, & Klerman, 
1978) or time to remission (Bearden, Lavelle, Buysse, Karp, & Frank, 1996; Feske, 
Frank, Kupfer, Shea, & Weaver, 1998). In a study of maintenance IPT, Frank and 
colleagues (2007) reported that there were no significant differences among demographic 
or clinical characteristics between women requiring IPT and pharmacotherapy to achieve 
remission, and those requiring only IPT.  However, the NIMH TDCRP suggested that 
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age, gender, and marital status were predictive of outcome within the four treatments 
examined in the study (IPT, CBT, imipramine plus clinical management, and placebo 
with clinical management; Sotsky et al., 1991). The authors noted, though, that there may 
have been a greater chance for findings in the study, given the size of the samples and the 
number of initial patient variables that were examined (1991).   
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5.0 INTERPERSONAL PSYCHOTHERAPY AND PERSONALITY 
 
 
 
Some interesting work has also been conducted on the contribution of personality 
pathology to outcome in IPT, in part because of the frequent comorbidity of depression 
and personality disorders widely reported in the depression literature (e.g., Hirschfeld, 
1999; Skodol et al., 1999). A number of researchers have explored the impact of 
personality disorders on the outcome of treatment for depression (Zuckerman, Prusoff, 
Weissman, & Padian, 1980; Shea et al., 1990; Bearden et al., 1996; Wolfson et al., 1997; 
Cyranowski et al., 2004). Not only has personality been associated with depression, it has 
also been identified as playing a role in the approach to IPT. As Stuart and Robertson 
(2003) explain, IPT views the patient’s functioning “as a product of his or her 
temperament, personality, and attachment style […] in the context of social relationships 
and broad social support” (p. 4). These authors also note that the interpersonal deficits 
problem area, called interpersonal sensitivity by Stuart and Robertson, is often associated 
with personality disorders or avoidant personality traits. For these reasons we plan to 
explore the role of personality pathology as one of the patient characteristics affecting 
treatment success among patients in the four problem areas of IPT. The previous research 
conducted on the effect of personality on treatment for depression is described below. 
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 In one analysis of the NIMH TDCRP (Elkin et al., 1989), Shea and colleagues 
(1990) found that although both those with personality disorders and those without 
showed a reduction in their depressive symptoms, those with personality disorders 
improved to a lesser degree and were more likely to have residual symptoms of 
depression. However, these differences were not statistically significant and were 
measured across all treatment conditions (1990). 
 In a study of IPT for depressed outpatients, Bearden and colleagues (1996) found 
that those with personality pathology were less likely to respond to IPT and those who 
did respond had a much longer time to remission. Cyranowski and colleagues (2004) 
examined the effect of personality pathology on treatment outcome using maintenance 
IPT for a group of depressed women. The results suggest that those with personality 
pathology experienced higher rates of recurrence and shorter time to recurrence than 
those who did not exhibit these symptoms (2004). While Luty, Joyce, Mulder, Sullivan, 
and McKenzie (1998) did not measure the influence of personality on treatment outcome, 
they noted that personality may have an effect on the patient’s presenting problem area.  
 In summary, the general effectiveness of IPT for depression has been well 
supported, but the effectiveness of treatment in each of the four problem areas has 
received little attention. While many patients come to therapy for the treatment of 
depression, the life events and more chronic interpersonal personal problems associated 
with the onset of these depressive episodes differ, and are thus treated somewhat 
differently within the IPT framework. While we are confident in the efficacy of IPT 
overall, we want to ensure that a lack of improvement in one problem area is not being 
masked by excellent outcomes in another. In an effort to identify the specific contexts, 
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individual characteristics, and interpersonal problems that are best treated by IPT, we will 
compare the success of treatment among patients whose treatment focused on each of the 
four problem areas identified as possible foci of treatment in this therapeutic model. We 
aim to identify the specific problem areas in which IPT is more or less effective and the 
common personal characteristics of individuals in each area. To do so, we will compare 
patient factors that may differ from subject to subject in the population under study. We 
hope to provide some evidence for the specificity of IPT and to understand why one 
problem area may be more difficult to treat than another.  
 17
  
 
6.0 GOALS 
 
 
 
One aim of this study is to understand how the interpersonal problem or problems most 
closely linked to the onset of an individual’s current depression can contribute to the rate 
of success of IPT. We are interested to determine if characteristics unique to the 
individuals whose treatment is focused on each of the IPT problem areas contribute to the 
rate of IPT’s success in reducing depressive symptomatology. One area we will explore 
in specific is the role of personality pathology; we expect that the group of individuals 
whose therapy focuses on interpersonal deficits will be more likely to have personality 
pathology that is comorbid to their depression than those whose therapy focuses on 
another problem area. If this additional pathology is present, perhaps it could help us to 
explain any differences in the rate of remission experienced in the interpersonal deficits 
group. Although we do not expect that demographic or clinical variables of the patients 
will be associated with time to remission, we will investigate these associations.
 Similarly, situational influences may have an impact on individuals whose 
therapy focuses on the role disputes problem area. In this problem area, the depression is 
often the result of conflict between two individuals that leads to the role dispute, whereas 
in the other problem areas the focus is more squarely on the patient’s difficulties.  It may 
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be more difficult to resolve interpersonal problems when two individuals’ needs must be 
taken into account, particularly if the other party to the dispute has no motivation to 
resolve it.  In contrast, in situations in which it is more exclusively the patient’s needs 
that are of significance, as in the case of grief or role transitions, therapeutic work may 
proceed more easily. Therefore, we expect that it would be more difficult for patients to 
achieve remission when their therapy focuses on role disputes than when the chosen 
problem area is role transition or unresolved grief.  
 We also expect that the interpersonal deficits problem area will be the most 
challenging problem area to treat, and that it will be associated with the longest time to 
remission. Patients whose therapy is focused on interpersonal deficits are described as 
having a history of social isolation, difficulty in forming and maintaining relationships 
with others, and are often more severely ill than patients in the other three problem areas 
(Stuart & Robertson, 2003; Weissman et al., 2000). Similarly, it is speculated that this 
problem area likely “carries the worst prognosis” (Markowitz & Swartz, 2007, p. 225) 
and may be better described as a long-standing attachment or personality style, rather 
than a response to a stressful life event (2003). Markowitz (2003) also notes that patients 
with interpersonal deficits may be more difficult to treat, explaining “One reason for this 
is that they are sicker patients, isolated and lacking in social supports, and more 
uncomfortable around other people, including their therapist. Another reason is that they 
lack the recent life events that IPT targets” (p. 849). As such, work in this problem area 
addresses more enduring pervasive problems in patients who may have more acute 
symptoms. Therefore, we expect that individuals whose therapy addresses interpersonal 
deficits will have a longer time to remission than the other three problem areas.  
 19
  
 
7.0 METHODS 
 
 
 
7.1 PARTICIPANTS 
 
This sample of 181 men and women was obtained from subjects participating in the study 
entitled, Depression: The Search for Treatment Relevant Phenotypes, Principal 
Investigator, Ellen Frank, Ph.D. Although 186 patients ultimately completed the study, at 
the time of analyses, data were available on only 181 of these patients. This two-site 
study was conducted at the University of Pittsburgh Medical Center’s Depression and 
Manic Depression Prevention Program, part of the Western Psychiatric Institute and 
Clinic (WPIC), and at the Department of Psychiatry, Neurobiology, Pharmacology, and 
Biotechnology at the University of Pisa, Italy. Ninety-seven of the subjects were studied 
at the University of Pittsburgh, and 84 were studied at the University of Pisa.  
 The subjects ranged in age from 18 to 64 and met criteria for a current episode of 
non-psychotic unipolar major depression, as defined by the Diagnostic and Statistical 
Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR; American 
Psychiatric Association, 2000). This diagnosis was verified by the use of the Structured 
Clinical Interview for Axis I DSM-IV Disorders (SCID-I; First, Spitzer, Gibbon, & 
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Williams, 1997) and by a rating of 15 or greater on the 17-item Hamilton Rating Scale 
for Depression (HRSD-17; Hamilton, 1960). Patients who were already receiving 
effective treatment were not accepted into the study; additionally, the females were 
practicing an acceptable form of birth control and did not plan to become pregnant during 
the course of the study.   
 None of the subjects met the following exclusion criteria: a diagnosis of antisocial 
personality disorder, bipolar disorder, schizophrenia, schizoaffective disorder, or an 
organic affective disorder. They also did not meet criteria for drug and/or alcohol 
dependence in the three months preceding entry into the study, nor did they meet criteria 
for a primary diagnosis of anorexia nervosa or bulimia nervosa. The presence of an Axis 
II disorder was diagnosed using the Structured Clinical Interview for DSM-IV 
Personality Disorders (SCID-II; First, Gibbon, Spitzer, & Williams, 1997). Additionally, 
subjects who were previously intolerant of one of the study treatments, or who required 
inpatient treatment for psychosis or suicidal risk were excluded from the study. 
 In Pittsburgh, subjects were recruited through fliers distributed to WPIC clinics, 
medical professionals, and community organizations, and through public service 
announcements. At Pisa, because Italian law prohibits the announcement of clinical 
studies in public places or in the media, recruitment relied on the flow of patients 
attending the outpatient psychiatric clinic and on word of mouth. To increase 
participation, efforts were made to encourage referrals from primary care physicians. 
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7.2 PROCEDURES 
 
Participants who entered into the study were randomly assigned to one of two conditions, 
psychotherapy or pharmacotherapy, which consisted of the SSRI escitalopram oxalate 
provided by a research psychiatrist. Those who were assigned to the psychotherapy 
condition, the 181 individuals in our sample, received IPT for approximately 45 to 50 
minutes per week from their assigned therapist.  At Pittsburgh, therapists were social 
workers, psychologists or nurse clinicians.  At Pisa, therapists were recent graduates of 
the psychiatric residency training program.  All therapists received training and 
supervision in IPT from an experienced research clinician, and they participated in 
regular group supervision at their respective sites throughout the course of the study. 
 After the first several sessions of IPT, the therapist and patient agreed upon a 
primary area of focus from among the four IPT problem areas. For some patients who 
were initially randomized to IPT, both a primary and a secondary problem area were 
agreed upon if it was felt that the patient’s concerns would be better addressed by a 
broader conceptualization. In the overall sample roughly 70% of the participants were 
assigned a secondary problem area at least one time point. This is particularly important 
with regard to the interpersonal deficits area: if a patient’s concerns fit this treatment 
focus, it was chosen as a secondary focus 50% of the time (n=11) as it is often easier to 
begin treatment with the grief, role disputes, or role transitions problem areas. However, 
this only occurred if the patient described problems that could also be addressed by 
exploring one of the other three problem areas, which was chosen as the primary focus. 
Given our hypothesis regarding those in the interpersonal deficits problem area, and the 
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fact that clinicians may be more likely to choose interpersonal deficits as a secondary 
problem area even if it is the main difficulty the patient is facing, we have defined the 
interpersonal deficits group as being comprised of any patient whose primary or 
secondary focus was identified as interpersonal deficits.  
 In this study, treatment “success” is measured by time to remission of depression 
in terms of days as it provides the most precise measure. Subjects were assessed weekly 
by an independent evaluator to measure their level of depressive symptoms. This 
evaluation was used at visit 7 to determine if response criteria had been met, defined as at 
least a 50% reduction of the baseline HRSD-17 score. If the criteria for improvement had 
not been met by visit 7, pharmacotherapy was added. If the response criteria had been 
met, subjects continued with IPT alone until visit 13, another triage point. At this point, 
patients were re-assessed to determine if stabilization criteria, or “remission,” had been 
met; this was defined as a mean HRSD-17 score of 7 or below over a 3 week period. 
Again, if the criteria were not met at this point, escitalopram was added. This procedure 
was also carried out at visit 21, if stabilization or remission had not been met. If the 
subject met the initial response criteria by visit 7 but later worsened, and therefore did not 
meet stabilization criteria by either visit 13 or 21, escitalopram was added at one of these 
later points as well. An alternative pharmacotherapy strategy could be applied if the 
subject had not met stabilization criteria by visit 21.  
 Of those who received medication, the most common time points for the addition 
of escitalopram were visit 7 (58.0%) and visit 13 (10.1%). Although the majority of 
patients receiving medication began the treatment at one of the specified triage points, 
some individuals began pharmacotherapy at other time points throughout the study, as 
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medically indicated. Appropriately, individuals who had pharmacotherapy added to their 
treatment likely remained in the study longer both because their depression proved more 
difficult to treat, thus requiring medicine, and because of the additive design of the study. 
 Typically, a subject could remain in the acute phase of the protocol for a 
maximum of 32 weeks, even if remission had not been achieved by that point. Those who 
did not achieve remission by week 32 were evaluated to determine if continued treatment 
was clinically appropriate. If so, they could receive up to 64 weeks of treatment. This 
study will examine only those subjects who were initially assigned to the IPT condition, 
regardless of whether or not they required the addition of the pharmacotherapy treatment. 
 
 
 
7.3 MEASURES 
 
 A diagnosis of depression was initially made using the Structured Clinical 
Interview for Axis I DSM-IV Disorders (SCID-I; First, Spitzer, et al., 1997) and a score 
of 15 or higher on the 17-item Hamilton Rating Scale for Depression (HRSD-17; 
Hamilton, 1960). The HRSD-17 was used to assess the severity of depressive symptoms 
at each clinic visit. Personality disorders were diagnosed using the Structured Clinical 
Interview for DSM Personality Disorders (SCID-II; First, Gibbon, et al., 1997), while 
level of personality pathology was measured by counting the sum of positive probes 
endorsed on the SCID-II. Both subthreshold and full threshold items that were endorsed 
on the SCID-II were counted in deriving the continuous score of personality pathology 
 24
for each patient as we wanted to take into account any personality pathology that may 
have been missed when identifying disorder diagnoses. In addition to depression, other 
Axis I disorders were also diagnosed using the SCID-I. When identifying these disorders, 
any diagnosis that met criteria for a current or lifetime full threshold disorder was 
included; subthreshold diagnoses were excluded as their effect on the treatment of 
depression may not have been as profound.  
 
 
 
 
7.4 AIMS AND HYPOTHESES 
 
The aim of the current study is to compare the groups of patients in each problem area on 
time to remission. As we expect that these groups will demonstrate significantly different 
times to remission, we hope to identify possible patient characteristics that may lead to 
these differences in success. We hypothesize:  
1. Individuals whose therapy is focused on interpersonal deficits have more personality 
pathology, as measured by the sum of the individual probes endorsed on the SCID-II 
interview, than those whose therapy is focused on the other three problem areas. 
2. Individuals whose therapy is focused on interpersonal deficits have more personality 
diagnoses, as assessed by the SCID-II interview, than those whose therapy is focused on 
the other three problem areas.                                                                                                
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3. Individuals whose therapy is focused on interpersonal deficits have a longer time to 
remission (defined as 3 consecutive weeks during which the patient’s HRSD-17 score 
averages < 7), than those whose therapy is not focused on interpersonal deficits. 
4. Individuals whose therapy is focused on role disputes have a longer time to remission, 
(defined as 3 consecutive weeks during which the patient’s HRSD-17 score averages      
< 7), than those whose therapy is focused on grief or role transitions. 
 
 
 
 
7.5 DATA ANALYSES 
 
Subjects initially assigned to the IPT condition were analyzed together using SPSS for 
windows; SAS for windows was utilized for one analysis of the Cox Proportional Hazard 
Model. Although conventional levels of statistical significance were set (p≤.05), 
exploratory analyses were conducted on some results reaching a trend level (p≤.10). Prior 
to testing the hypotheses, an analysis of variance (ANOVA) was conducted to test for 
differences among the four treatment focus groups on the demographic and clinical 
variables. Post-hoc tests were conducted to identify differences between the means of 
pairs of problem area groups using the Hochberg test. The Games-Howell test was 
substituted for comparisons in which the variances among the four groups were unequal, 
likely a result of the unequal sizes of each group. There was also some suggestion that the 
normality assumption was not met for a few of the continuous variables. Both parametric 
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and non-parametric tests were conducted with results indicating consistent findings. 
Thus, the ANOVA results are reported here. 
 The Cox Proportional Hazards Model was used to determine if any demographic 
or clinical variables or problem area assignment had an effect on time to remission; these 
variables were entered into the model together in two hierarchical steps. This model was 
also utilized to determine if the patient’s level of personality pathology, measured 
continuously, and the addition of medication had an effect on time to remission when 
entered into the model alone. Here, the addition of medication was examined as a time-
varying covariate as not all patients who received medication received it at the same time. 
 With regard to analyses conducted to test the four hypotheses, the chi-square test 
was utilized to compare the interpersonal deficits group and the combination of the other 
three problem area groups on the proportion of patients reporting at least one personality 
disorder. In order to compare these two groups of patients on the continuous level of 
personality pathology that they reported, the Wilcoxon Rank Sum Test was used. Kaplan-
Meier survival curves were created to characterize the time to remission of the four 
problem area groups. The Log Rank Test was used to compare the interpersonal deficits 
group to the other three groups combined on time to remission, and to compare the role 
disputes to the grief and role transitions group on this measure. 
 Exploratory analyses were then conducted to examine possible differences 
between patients at each site regarding to time to remission and the demographic and 
clinical variables. Additionally, analyses were conducted to determine if the addition of 
medication was associated with any patient characteristics, or if the frequency or timing 
of the addition of this second treatment differed among the four problem area groups. 
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8.0 RESULTS 
 
 
 
A summary of demographic information by problem area is listed in Table 1. The sample 
is made up primarily of Caucasian, well-educated females. An analysis of variance 
revealed that the four problem area groups differed on age (F=3.448, p=0.018), age at 
first depressive episode (F=3.673, p=0.013), the presence of at least one additional full 
threshold lifetime or current Axis I disorder (F=3.632, p=0.014), and the proportion of 
patients in each problem area group at each site (F=6.595, p=0.0001). Differences in the 
proportion of each group who were married did not reach conventional levels of 
statistical significance (F=2.292, p=0.08). 
 Based on these findings, post-hoc comparisons using the Hochberg and Games-
Howell tests were conducted to identify differences between the means of pairs of 
problem area groups. These tests revealed that the role disputes group was older and 
more likely to be married than the role transitions group, while the role transitions group 
was more likely to have an additional Axis I disorder than the role disputes group. The 
results also showed that the role transitions group had an earlier age of first depressive 
episode than patients in the grief groups. These post-hoc comparisons reach a trend level 
of significance. Lastly, of patients whose treatment focused on role transitions,  
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Table 1. Demographics and Clinical Characteristics of the Sample 
 
 Grief 
 
N=16 
Inter. 
Deficits 
N=22 
Role 
Disputes 
N=72 
Role 
Transitions 
N=71 
All 
Groups 
N=181 
F 
Mean Age (S.D.)  42.92 
(3.21) 
42.43  
(2.69) 
40.59  
(1.45) 
35.39 
(1.49) 
38.98 
(0.95) 
3.448** 
Sex (Female) 87.5% 63.6% 73.6% 64.8% 70.2% 1.379 
Ethnicity 
(Caucasian) 
75.0% 90.9% 94.4% 88.7% 90.1% 1.938 
Mean Education 
Level in Years 
(S.D.) 
 
13.67 
(0.60) 
13.41  
(0.65) 
13.82 
(0.41) 
14.74  
(0.33) 
14.13 
(0.24) 
1.588 
Employed/Student 93.8% 81.8% 78.6% 74.6% 78.8% 0.922 
Married or Living 
with a Partner 
25.0% 36.4% 48.6% 29.6% 37.6% 2.292* 
Mean Age at First 
Episode (S.D.)  
 
32.44 
(4.10) 
23.00 
(2.76) 
28.66 
(1.46) 
23.73 
(1.36) 
26.35 
(0.95) 
3.673** 
Mean Number of 
Previous Episodes 
(S.D.) 
4.36 
(2.60) 
3.00 
(0.78) 
2.241 
(0.19) 
3.34 
(0.49) 
2.98 
(0.22) 
1.291 
Medication Added 31.3% 36.4% 34.7% 45.1% 38.7% 0.535 
Baseline HRSD-17 
Score  
19.94 
(0.99) 
19.41  
(0.79) 
19.86 
(0.41) 
19.51  
(0.46)  
19.67  
(3.67) 
0.175 
Other Axis I 
Disorders 
37.5% 54.5% 47.2% 70.4% 56.4% 3.632** 
One or more Axis 
II Disorders  
33.3% 45.5% 31.9% 22.5% 30.0% 1.537 
Site (Pittsburgh) 43.8% 40.9% 40.3% 73.2% 53.6% 6.595** 
Remitted 87.5% 72.7% 88.9% 78.9% 82.9% 1.495 
*p<0.10 
**p<0.05
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significantly more of them participated in the study at Pittsburgh than patients whose 
treatment focused on role disputes. 
 With regard to the effect of demographic and clinical variables on time to 
remission, Table 2 outlines the results of a Cox Proportional Hazards model including 
these variables. At the first stage of the model age, sex, education level, marital status 
(married or living with a partner vs. not), ethnicity (Caucasian vs. not), and employment 
status (employed or a student vs. not) were entered into the model; patients reporting a 
higher level of education experienced a longer time to remission (Exp(ß)=0.931, 
p=0.015). Next, age at first depressive episode, number of previous depressive episodes, 
baseline HRSD-17 score, the presence of at least one additional full threshold current or 
lifetime Axis I disorder, the presence of at least one Axis II disorder, site, and problem 
area assignment were added to the model. At this stage, the effect of education 
diminished. However, patients in Pittsburgh (Exp(ß) =2.752, p=0.0001) and patients with 
a higher baseline HRSD-17 score (Exp(ß) =0.923, p=0.003) experienced a longer time to 
remission. Patients with at least one personality disorder also experienced a longer time 
to remission at a trend level (Exp(ß)=0.692, p=0.092). 
 It is important to keep in mind that, as Table 3 shows, site appears to be 
significantly correlated with a number of variables such as education, ethnicity, sex, 
education level, baseline HRSD-17 score, and the presence of an additional Axis I 
disorder. Thus, it is possible that at the second stage of the model site may be masking a 
potentially significant relationship between these variables and time to remission. 
Specifically, the significant relationship between education and time to remission 
diminished when site was added to the model. 
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Table 2.  Relationship between Demographic and Clinical Variables and Time to 
Remission using the Cox Proportional Hazards Model 
 
Model Variable Exp(ß) Significance 
(1) Age 0.994 0.428 
 Education 0.931 0.015* 
 Sex 0.953 0.803 
 Married 1.258 0.247 
 Employed 1.010 0.967 
 Ethnicity 0.769 0.416 
(2) Age 0.996 0.734 
 Education 0.996 0.903 
 Sex 1.033 0.874 
 Married 1.341 0.146 
 Employed 0.762 0.299 
 Ethnicity 1.310 0.437 
 Site 2.752 0.0001* 
 Age at first episode 1.003 0.838 
 Number of previous 
episodes 
1.003 0.614 
 Other Axis I 
Disorders 
0.816 0.355 
 One or more Axis II 
Disorders 
0.696 0.092 
 Problem Area 1.060 0.630 
 HRSD-17 0.923 0.003* 
* Variable is a significant predictor of time to remission 
Table 3. Correlations among Clinical and Demographic Variables 
 
 Site Age Educ. Sex Ethnicity Married Employed Age at 
First 
Episode 
# of 
Previous  
Episodes 
Other  
Axis I 
Disorders 
Axis II 
Disorders 
HRSD-
17 
Site -            
Age -0.006 -           
Educ. -0.499* -0.011 -          
Sex -0.219* -0.065 0.154* -         
Ethnicity -0.205* -0.034 0.014 0.140 -        
Married 0.079 0.405* -0.072 -0.082 -0.143 -       
Employed 0.093 -0.268* 0.154* 0.073 -0.089 -0.100 -      
Age at  
First 
Episode 
0.188* 0.471* -0.151* -0.032 -0.033 0.299* -0.041 -     
# of 
Previous 
Episodes 
-0.011 0.072 0.047 0.023 0.055 -0.026 -0.042 -0.363* -    
Other  
Axis I 
Disorders 
-0.298* -0.040 0.164* 0.063 0.173* 0.016 -0.010 -0.244* 0.039 -   
Axis II 
Disorders 
-0.022 -0.071 0.046 0.074 0.121 -0.103 0.016 -0.125 0.070 -0.064 -  
HRSD-17 0.065 0.144 -0.187* -0.041 0.211* 0.010 -0.169* 0.064 0.023 0.010 -0.006 - 
*p<0.05
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 Examining the potential differences among the groups on personality pathology, 
both categorical and continuous measures were used, as some patients may have had  
personality pathology that did not meet criteria for a specific diagnosis but that is 
nonetheless clinically significant. The first hypothesis states that individuals whose 
therapy is focused on interpersonal deficits have more personality pathology, as measured 
by the sum of the individual probes endorsed on the SCID-II interview, than those whose 
therapy is focused on the other three problem areas. The Wilcoxon Rank Sum Test 
showed that the interpersonal deficits group did not differ significantly from the other 
three problem area groups on mean level of personality pathology (W=14363.5, p=0.908). 
As the normality assumption was not met for the distribution of the personality pathology 
variable, shown by the Kolmogorov-Smirnov test (K-S=0.121, p=0.0001), the Wilcoxon 
Rank Sum test was utilized for this analysis. The second hypothesis states that individuals 
whose therapy is focused on interpersonal deficits have more personality diagnoses than 
those whose therapy is focused on the other three problem areas. Here, a chi-square test 
between these two groups of patients on the presence of one or more personality 
disorders revealed a non-significant trend (X2=2.851, p=0.091) for higher likelihood of a 
personality diagnosis in the deficits group, as is shown in Table 1.  
 Of the 181 individuals included in the analysis of time to remission, 31 (17.1%) 
were considered censored observations. Of these, 24 (77.4%) were considered 
informative observations as the reason they did not remit seemed to be related to their 
depression. Examples include non-adherence to treatment, non-response to treatment, 
relapse, or being lost to follow-up. The remaining 7 (22.6%) individuals were considered 
non-informative observations; typical reasons for termination among this group included 
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relocating to a different city or a change in diagnosis. Thus, 150 patients achieved 
remission by the end of their time in the study. 
 In order to test the differential effectiveness of IPT based on our hypotheses 
Kaplan-Meier curves were created for each of the four groups. As Figure 1 demonstrates, 
the survival times among the four problem area groups are quite similar. The median time 
to remission among all participants was 81 days (roughly 11.6 weeks) with a standard 
error of 4.287 days. To test our third hypothesis, that individuals whose therapy is 
focused on interpersonal deficits have a longer time to remission than all other patients, 
Kaplan-Meier curves were created to show the survival times of the interpersonal deficits 
group and the other three groups combined. These curves are shown in Figure 2. The Log 
Rank Test was used to compare these two groups of participants on time to remission. 
Contrary to prediction, the interpersonal deficits group did not show a longer time to 
remission than the other three groups combined (X2=0.438, p=0.508).  
 To test the fourth hypothesis, that individuals whose therapy is focused on role 
disputes have a longer time to remission than those whose therapy is focused on grief or 
role transitions combined, another set of Kaplan-Meier curves was created to show the 
times to remission of these two groups, as shown in Figure 3. The interpersonal deficits 
group was left out of this analysis; as it was originally hypothesized that this group would 
be more difficult to treat than the others, we compared only the role transitions and grief 
groups to the role disputes group as planned. These three groups share the similarity of 
typically experiencing a life event as a precipitant to their depression, while those in the 
deficits group typically do not. The Log Rank Test showed no difference in time to 
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Figure 1. Days to remission by problem area.
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Figure 2. Days to remission comparing interpersonal deficits and the other three problem 
area groups. 
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Figure 3. Days to remission comparing the role disputes problem area group with the 
grief and role transition problem area groups 
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remission between these two groups (X2=0.773, p=0.379). Moreover, exploratory 
analyses revealed no significant differences when comparing the time to remission of the  
grief group and the other three groups (X2=0.473, p=0.491) or the role transitions group 
and the other three groups (X2=0.025, p=0.874). 
 The Cox Proportional Hazard Model was utilized to determine the effect of 
personality pathology, measured continuously, on time to remission. When entered into a 
univariate model it appears that endorsing a greater number of probes on the SCID-II is 
associated with a longer time to remission at a trend level (Exp(ß)=0.992, p=0.056). This 
variable was excluded from the hierarchical model described above as it is so highly 
correlated with the categorical measure of personality pathology, as shown in Table 3. 
We also hoped to understand the potential effect of the addition of medication on a 
patient’s time to remission. However, not all patients received medication, and the 
addition of medication occurred at varying time points depending on the patient’s need; 
thus, we considered the addition of medication to be a time-varying covariate. In this 
case, the addition of medication was associated with a decreased time to remission  
(ß=-0.78, p=0.0006). 
 We also hoped to understand if the addition of pharmacotherapy interacted with 
problem area assignment. Using the Cox Proportional Hazard Model we found that time 
to remission did not differ between patients whose treatment focused on interpersonal 
deficits and all other patients as a result of the addition of medication (ß=0.44, p=0.41). 
Thus, assignment to the deficits problem area and the addition of medication did not 
interact significantly to produce an effect on time to remission. 
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 Based on the fact that individuals who received medication experienced a shorter 
time to remission than patients who received IPT alone, we conducted exploratory 
analyses to determine if the addition of medication was associated with any patient 
characteristics. Medication was added to IPT in 38.7% of the overall sample with equal 
frequency across the four problem area groups (X2=2.120, p=0.548). As well, the time 
points at which medication was added did not differ significantly among the four groups 
(X2=2.224, p=0.527). We conducted chi-square analyses to determine which patient 
factors, if any, were associated with the addition of medication. It appears that the 
presence of additional lifetime or current Axis I disorders is associated with the addition 
of medication (X2=5.402, p=0.020), which is expected given that additional pathology 
may increase the complexity of a patient’s clinical picture. Males were also more likely 
to receive medication (X2=9.248, p=0.002), suggesting that the treatment of depression in 
men may be more difficult than it is among women. In fact, in the overall study it appears 
that men were more difficult to treat with both IPT alone and pharmacotherapy alone (E. 
Frank, personal communication, July 30, 2008); thus, it may not be that men experience a 
poorer outcome with IPT, but that they are more difficult to treat in general.  
 As site was strongly correlated with a number of patient variables, we chose to 
examine differences among patients at each site. Patients at Pisa experienced a 
significantly shorter time to remission than at Pittsburgh (X2=17.730, p=0.0001). Kaplan-
Meier survival curves created to demonstrate this difference are shown in Figure 4. 
Moreover, it appears that patients at Pittsburgh and Pisa demonstrated different rates of 
remission reaching a trend level (X2=3.012, p=0.083), with a tendency for more Pisa 
patients to achieve remission. Although the patients at each site received the same 
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Figure 4. Time to remission among patients at Pittsburgh and Pisa. 
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psychotherapeutic treatment and there were no differences in the makeup of escitalopram 
used at each site, there may be some reasons for the significant differences in survival 
time. As is shown in Table 4, significantly fewer patients at Pisa required medication  
 (X2=28.639, p=0.0001), indicating that patients at Pisa experienced depression that was 
less difficult to treat. The Pittsburgh sample included more males (X2=8.712, p=0.003) 
and male gender was associated with longer time to remission. Patients at Pittsburgh 
experienced more current and lifetime Axis I disorders (X2=16.065, p=0.0001), higher 
levels of education (W=4938.500, p=0.0001), an earlier age of first depressive episode 
(W=7512.000, p=0.002), and more previous depressive episodes (W=4361.50, p=0.002), 
all variables associated with longer time to remission. Thus, in this sample site may be a 
proxy for these demographic and clinical variables. 
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Table 4. Patient Characteristics by Site 
 
 Pittsburgh 
N=97 
Pisa 
N=84 
Mean Age (S.D.) 39.06  
(1.34) 
38.89  
(1.33) 
Sex (Female) a 60.8% 81.0% 
Ethnicity (Caucasian)b 83.5% 97.6% 
Mean Education Level in 
Years (S.D.)c 
15.57  
(0.27) 
12.38  
(0.32) 
Employed/Student 75.3% 82.9% 
Married or living with a 
Partner 
34.0% 41.7% 
Mean Age at First 
Depressive Episode (S.D.)d 
24.16  
(1.30) 
28.92  
(1.35) 
Mean Number of Previous 
Episodes (S.D.) 
3.00  
(0.31) 
2.96  
(0.65) 
Medication Addede 56.7% 17.9% 
Baseline HRSD-17 Score  19.45  
(0.39) 
19.93  
(0.38) 
Other Current and 
Lifetime Axis I Disordersf 
70.1% 40.5% 
One or more Axis II 
Disorders 
30.9% 28.9% 
Remittedg 78.4% 88.1% 
The two sites differed as follows: 
a X2=8.712, p=0.003  e X2=28.64, p=0.0001 
b X2=10.01, p=0.002  f X2=16.07, p=0.0001 
c W=4938.5, p=0.0001 g X2=3.012, p=0.083 
d W=7512.0, p=0.002  
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9.0 DISCUSSION 
 
 
 
In an effort to provide evidence for the specificity of IPT, we used survival analyses to 
compare time to remission among depressed patients whose treatment focused on each of 
the four problem areas. We found that patients in each of the four groups experienced 
similar times to remission. Contrary to prediction, those in the interpersonal deficits 
group did not experience a longer time to remission than the other patients combined, nor 
did patients whose treatment focused on role disputes experience a significantly longer 
time to remission than patients whose treatment focused on grief or role transitions. 
Patients in each of the four groups differed on a few demographic and clinical variables. 
We expected individuals in the interpersonal deficits group to report more personality 
pathology given our clinical experience and the fact that this group has been described as 
the most difficult to treat and more likely to suffer from characterologic challenges 
(Markowitz & Swartz, 2007; Stuart & Robertson, 2003; Weissman et al., 2000); 
however, we did not find strong evidence to support this hypothesis.  
 With regard to other differences among the groups, patients whose treatment 
focused on role transitions reported an earlier age at onset of their depression than 
patients in the grief group, while patients whose treatment focused on role transitions 
reported more additional Axis I pathology than patients in the role disputes groups. These 
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findings may indicate a more endogenous depression among patients in the role 
transitions group. Patients in the role transitions group also appear to be younger than the 
patients in the role disputes group, while it appears as though there are a higher 
proportion of patients who are married or living with a partner in the role disputes group 
than in the role transitions group.  
 Although historically a number of studies have indicated that demographic and 
clinical variables are not related to time to remission, in the present study education level, 
treatment site, and baseline depression score were predictive of time to remission. 
However, education level was no longer predictive of remission when site was added to 
the model; as site is highly correlated with education level, among other variables, we 
need to consider the fact that when site is added to the model it may mask the true 
association between these variables and time to remission. With regard to baseline 
depression score, we expect that patients who enter treatment with more severe 
depressive symptoms may experience a longer time to remission. Nonetheless, this does 
not seem to have much of an impact on our findings given that our four groups did not 
differ significantly on time to remission or on baseline depression score.  
 There are several possible explanations for the lack of significant differences 
between the interpersonal deficits group and other three groups on time to remission. We 
predicted that individuals in the interpersonal deficits group would report more 
personality pathology, and that perhaps this, in, turn, would explain the differences that 
we predicted would exist regarding time to remission. However, at least in this 
population, it appears that choice of the deficits area was not necessarily associated with 
personality pathology, whether measured continuously or categorically. Thus, the lack of 
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significant differences regarding time to remission may be the related to the fact that 
individuals in the interpersonal deficits group did not actually report a clinical picture that 
was complicated by significantly greater Axis II pathology. 
 Another explanation for the lack of differences may be the possibility that the 
individuals whose treatment focused on interpersonal deficits are not truly representative 
of those whose treatment should really focus on this interpersonal challenge. As 
Markowitz (2003) notes, clinicians are encouraged to focus on any problem area other 
than interpersonal deficits, if at all possible. He explains, “Interpersonal deficits are used 
as an IPT focus only when the alternative, life-event-based foci are absent, which is 
relatively rare. The term interpersonal deficits is a misnomer that might better be termed 
no recent life events. Not surprisingly, patients clustered in this category have been 
associated with poorer outcome than in the other IPT categories” (p. 849). Seemingly, it 
is less of a challenge for both clinician and patient to address more concrete and specific 
concerns related to a recent life event or a single specific role dispute, if present, than 
more pervasive, but less specific social deficits that have persisted chronically.  
 Thus, a patient whose treatment could or should focus on interpersonal deficits 
but who also presents with another potential focus of treatment, as did most of the deficits 
patients in this study, may be identified as having two treatment foci, usually with the 
deficits problem listed as the secondary focus if at all possible. In this project any 
individual whose treatment focused on interpersonal deficits either as a primary or 
secondary focus of treatment at any time point was included in the interpersonal deficits 
group. The rationale for this is that we believe it likely that these individuals truly suffer 
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from interpersonal deficits, but that treatment was conceptualized as focusing on another 
problem area because of the difficulty in working with an interpersonal deficits focus.  
 Nonetheless, we must acknowledge the possibility that individuals for whom 
interpersonal deficits was listed as a secondary focus may have spent the majority of their 
treatment working on one of the other three treatment foci, resulting in more successful 
and efficient resolution of their depression than might be seen if interpersonal deficits 
was the sole focus. Only two out of 181 patients in this study were assigned a problem 
area focus of interpersonal deficits without a secondary focus. One of these patients 
remitted after 86 days in the study with medication added on day 63, while the other 
terminated treatment after 24 days, reportedly because the patient did not respond to 
treatment. This lone deficits focus is not only rare, but in the other deficits cases, without 
conducting a session-by session analysis of treatment content, it is difficult to know how 
much impact an interpersonal deficits focus had on treatment if it was not the sole focus. 
 The fact that those individuals in whom an interpersonal deficits problem area 
was noted appear to have been treated successfully by avoiding the interpersonal deficits 
focus (despite the fact that social deficits may have been their true challenge), provides 
further support for IPT as an effective and flexible treatment for patients whose 
depression may not primarily be related to a life event. In the present study it appears that 
if a patient’s depression can be resolved through work on a short-term interpersonal 
problem in the presence of social deficits, the current depressive episode may be resolved 
successfully. However, the treatment outcome of these patients may not be representative 
of patients whose treatment focused on interpersonal deficits alone. We also do not know 
whether challenges related to interpersonal deficits that were present all along but may 
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not have been addressed in treatment that was, instead, focused on an event-related 
problem, leave patients more vulnerable to subsequent relapse or recurrence. Even so, we 
may have reason to be encouraged; based on the two cases with a lone interpersonal 
deficits focus identified above, the patient who remitted did so in a time that is similar to 
the median survival time of all patients in the interpersonal deficits group (86 days for 
this patient vs. 81 days for the entire sample).  
 This project also predicted that those in the interpersonal deficits group would 
have significantly more personality pathology and personality diagnoses than those in the 
other three groups. We found only weak evidence to support this hypothesis. There was a 
non-significant trend for this group to have a higher probability of a personality disorders 
diagnosis. However, there were no differences among the groups with regard to 
personality pathology measured continuously with the SCID-II. Although organizing 
personality pathology into distinct diagnoses is clinically meaningful in most situations, 
perhaps the overall level of pathology reported by a patient has more of an effect on 
treatment of depression than whether this pathology is organized into disorders. 
 It appears that the majority of patients in this study with a personality disorder 
met criteria for a diagnosis in the cluster “C” category, such as avoidant, dependent, or 
obsessive-compulsive personality disorder. We would not expect individuals with cluster 
“C” disorders to be as difficult to treat as those with cluster “B” disorders; rather, the 
personality pathology symptoms endorsed by the majority of our patients naturally make 
them more isolative, avoidant, or anxious. It is possible that their personality pathology is 
concerning for them, but may not interfere directly with treatment. 
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 Our fourth hypothesis stated that patients whose treatment focused on role 
disputes would fare worse with IPT than patients whose treatment focused on grief or 
role transitions. Our reasoning was based on the potential difficulty in incorporating the 
needs of a second individual (the individual with whom the patient has the dispute) into 
treatment. One possible explanation for the equal success among these patients may be 
the strength of the IPT strategies that are utilized in all problem areas, such as exploration 
of feelings, the use of the sick role, and improving communication. Perhaps the success 
of IPT seen in this project as a whole reflects the value of these more general strategies, 
regardless of problem area focus. Particularly in a disputes case, however, IPT is open to 
including the other party to the dispute in a few sessions of treatment, which may help to 
facilitate open communication, and may promote the understanding of both the patient 
and the significant other’s feelings and nonreciprocal role expectations. 
 The fact that we did not find significant differences among the problem area 
groups is supported by the previous work of Wolfson and colleagues (1997) who found 
that IPT problem area is not associated with time to clinical response among older adults 
with depression. Although this earlier work did not include an interpersonal deficits 
group because of a small sample size in this problem area, the other three patient groups 
demonstrated similar treatment response. As in the present study, Wolfson and colleagues 
concluded that IPT, in the presence of carefully managed drug therapy, where 
appropriate, treats patients in each problem area with equal success. 
 Further analyses were conducted to explore how the addition of medication 
affected treatment outcome. The addition of medication indicated decreasing predicted 
survival time; that is, those who received medication appeared to remit more quickly than 
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those who received IPT alone. Including the addition of medication as a time-varying 
covariate allowed us see the effect of the addition of medication on time to remission 
only during the time period that the medication was added. It appears that patients who 
were not improving sufficiently with psychotherapy alone may have benefited from the 
addition of pharmacotherapy. We also did not find a significant difference in response to 
medication between the patients in the deficits group and all other patients, which could 
have had an effect on their time to remission. Thus, while the addition of medication may 
limit our ability to draw conclusions about the effect of IPT alone, this limitation appears 
to be consistent across all problem area groups.  
 In addition to medication, the continuous measure of personality pathology was 
the other variable entered into the Cox Proportional Hazards model independently to 
determine whether increased levels of this variable had an effect on time to remission. 
This variable was analyzed in a univariate model because a measure of personality 
pathology had already been entered into the stepwise model, and because the two 
variables were so highly correlated. In this univariate model, it appears that reporting a 
higher level of personality pathology was associated with an increased time to remission 
at a trend level, similar to the findings for the categorical measure of Axis II pathology. 
 Regarding site differences among the patients, the patients at Pisa experienced a 
significantly shorter time to remission than those at Pittsburgh. It appears that in this 
sample, site may be a proxy for other variables as these groups of patients differed 
significantly on a number of demographic and clinical variables that may have had an 
effect on time to remission. Lastly, it may also be important to examine the effects of 
informative or non-informative censoring on the success of treatment within each 
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problem area. Overall, most of the 31 censored patients’ drop-out was informative; it is 
possible that patients whose censoring was informative would have affected the group’s 
time to remission if they had not left the study. 
 
 
 
 
9.1 LIMITATIONS 
 
This study has several limitations. First, because patients are not randomly assigned to 
the problem areas under investigation, but collaboratively choose a treatment focus with 
their therapist based on their specific experience, the sample sizes of the grief and 
interpersonal deficits groups were much smaller than the role disputes and role transitions 
groups. This likely had an impact on our ability to detect a difference in survival times 
between the interpersonal deficits group and the other three groups. However, the median 
survival time for these groups was roughly 86 and 78 days, respectively; thus, even if we 
were able to detect a statistically significant difference this may not have been a clinically 
significant difference. 
 While clinically indicated and important for the larger goal of this study, the 
addition of pharmacotherapy limited our ability to interpret the differences among the 
problem area groups on time to remission based on treatment with IPT only. Although 
61.3% of participants received IPT alone, 38.7% received medication as well when their 
depression proved difficult to treat with IPT alone. Despite analyses investigating the 
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effect of the pharmacotherapy, it nonetheless limits our ability to draw conclusions about 
the effectiveness of IPT alone. Moreover, there are some individuals for whom 
medication was not added at the exact point it was deemed necessary according to the 
study protocol, usually because a patient missed a scheduled visit. Thus, in a few cases 
there may have been an unavoidable lapse between when medication was deemed 
necessary and when it was actually given.  
 With regard to patient characteristics, the generalizability of these findings may 
be limited somewhat given that the sample was primarily made up of Caucasian 
individuals, and that patients who were severely depressed were excluded from the study. 
Moreover, it is somewhat difficult to account for the effect of patients who may have 
dropped out of the study for reasons related to their condition. While patients with 
informative censoring were split relatively evenly among the four problem area groups, 
we cannot know the effect that these patients would have had on our findings if they had 
remained in the study. Lastly, several of the patients in the study reported interpersonal 
challenges that fell into more than one problem area. Thus, we cannot determine how 
much time was spent discussing problems related to the patient’s secondary problem 
area, which could have had an impact on the findings. 
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10. 0 CONCLUSIONS AND FUTURE DIRECTIONS 
 
 
 
This study examined the relative time to remission among the four problem area groups 
of depressed individuals receiving IPT, in particular aiming to identify patient 
characteristics that may contribute to the differential efficacy of IPT among this sample. 
Individuals whose treatment focused on interpersonal deficits did not report significantly 
more personality pathology than the patients in the other three problem areas, whether 
measured continuously or categorically. Contrary to prediction, individuals in the 
interpersonal deficits problem area did not demonstrate a longer time to remission than 
the remainder of the sample, nor did individuals in the role disputes group demonstrate a 
longer time to remission than patients in the grief and role transitions groups. Thus, with 
the skillful use of IPT strategies and tactics and with careful medication management, 
where appropriate, patients in this study whose treatment focused on each problem area 
were treated with equal success by experienced IPT clinicians. 
 Future studies should continue to focus on characteristics of both patients and 
treatment to identify factors that may contribute to the differential efficacy of IPT in 
depressed adults. With a larger sample it would be possible to differentiate among the 
types of role transitions, the different individuals with whom a patient might be having a 
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role dispute, or the relationship between the patient and the individual who died in a grief 
case in order to determine whether these various relationships and situations have a 
differential effect on treatment outcome. Likewise, with a larger sample it would be 
possible to compare individuals whose treatment focused primarily on interpersonal 
deficits to those who focused secondarily on the deficits problem area; it is possible that 
there may be differences in time to remission among these groups depending on the 
extent to which an interpersonal deficits problem was the true focus of treatment. Finally, 
future studies may more accurately predict the time to remission of individuals whose 
treatment focuses on interpersonal deficits by asking clinicians to note the problem area 
of focus in treatment, as well as the problem area that the clinician would have liked to 
have focused on, if they differ.  
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